Earnings Call
AbbVie Inc. (ABBV) Q4 2024 Earnings Call Transcript
Presentations
company representative·Additional Participants
company representative
Liz Shea - Senior Vice President, Investor Relations
Rob Michael - Chief Executive Officer
Jeff Stewart - Executive Vice President, Chief Commercial Officer
Roopal Thakkar - Executive Vice President, Research & Development, Chief Scientific Officer
Scott Reents - Executive Vice President, Chief Financial Officer
Carrie Strom - Senior Vice President of AbbVie, and President of Global Allergan Aesthetics
Additional Participants
Vamil Divan - Guggenheim Securities
Chris Schott - J.P. Morgan
Geoff Meacham - Citigroup
Terence Flynn - Morgan Stanley
Mohit Bansal - Wells Fargo
David Risinger - Leerink Partners
Steve Scala - TD Cowen
Tim Anderson - Bank of America
Chris Raymond - Piper Sandler
Trung Huynh - UBS
Chris Shibutani - Goldman Sachs
Operator
Good morning and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only until the question-and-answer portion of this call. [Operator Instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time.
I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Ma'am, you may begin.
I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Ma'am, you may begin.
Liz Shea
Thank you. Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research & Development, Chief Scientific Officer; Scott Reents, Executive Vice President, Chief Financial Officer; and Carrie Strom, Senior Vice President, AbbVie, and President, Global Allergan Aesthetics.
Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on our current expectations. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause
Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on our current expectations. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause